Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	CIT Experienced: Sitravatinib and Nivolumab	124
Overall Study	STARTED	CIT Naïve: Sitravatinib and Nivolumab	32
Overall Study	STARTED	Glesatinib and Nivolumab	5
Overall Study	Received Any Study Treatment	CIT Experienced: Sitravatinib and Nivolumab	124
Overall Study	Received Any Study Treatment	CIT Naïve: Sitravatinib and Nivolumab	32
Overall Study	Received Any Study Treatment	Glesatinib and Nivolumab	5
Overall Study	COMPLETED	CIT Experienced: Sitravatinib and Nivolumab	0
Overall Study	COMPLETED	CIT Naïve: Sitravatinib and Nivolumab	0
Overall Study	COMPLETED	Glesatinib and Nivolumab	0
Overall Study	NOT COMPLETED	CIT Experienced: Sitravatinib and Nivolumab	124
Overall Study	NOT COMPLETED	CIT Naïve: Sitravatinib and Nivolumab	32
Overall Study	NOT COMPLETED	Glesatinib and Nivolumab	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02954991/flow